Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Neptune › NPI 1790297547
Hospital

HMH Hospitals Corporation

HMH Hospitals Corporation was paid $128.23M by Medicaid between Feb 2018 and Dec 2024, across 519 billing codes. Its largest line is G0378, Hospital observation service, per hour — 13% of everything it billed.

33Billing provider infoHMH HOSPITALS CORPORATION
NEPTUNE, NJ 07753
33aNPI1790297547assigned 11/02/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$128.23M
24GClaims1,935,584
24DCodes billed519
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#15 of 93
Median peer was paid$30.60M
This provider vs. median4.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HAND, RICHARD controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201892,786$7.71M
2019237,909$20.77M
2020207,402$14.80M
2021291,538$19.37M
2022362,058$21.01M
2023405,211$23.02M
2024incomplete338,680$21.55M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0378 Hospital observation service, per hour 13% 15,233 13,297 $16.71M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 46,123 41,346 $16.60M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 52,151 46,370 $15.69M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.5% 23,475 20,083 $4.45M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.2% 4,820 2,974 $4.07M
S9480 Intensive outpatient psychiatric services, per diem 3.2% 4,979 4,252 $4.07M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.0% 16,262 14,778 $3.91M
41899 Unlisted procedure, dentoalveolar structures 2.7% 3,979 3,884 $3.51M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.7% 47,806 12,465 $3.41M
H0035 Mental health partial hospitalization, treatment, less than 24 hours 2.3% 10,376 1,252 $2.97M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.6% 12,330 10,769 $2.07M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.5% 2,173 2,066 $1.88M
507 more codes
OP370 1.4% 16,995 $1.76M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.3% 3,402 $1.68M
OP710 1.3% 16,728 $1.66M
90832 Psychotherapy session, about 30 minutes 1.2% 15,993 $1.57M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.2% 1,253 $1.54M
96375 Therapeutic injection; each additional sequential IV push 1.1% 16,169 $1.44M
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.0% 23,731 $1.29M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 13,539 $1.19M
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 526 $1.14M
99214 Doctor's office visit, returning patient (more involved) <1% 4,071 $985K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 10,716 $969K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 7,540 $860K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 34,401 $860K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,703 $828K
OP278 <1% 1,057 $822K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,011 $815K
76819 Fetal biophysical profile; without non-stress testing <1% 9,110 $795K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 605 $770K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 11,126 $756K
95816 <1% 1,436 $744K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 5,096 $702K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 402 $688K
96415 <1% 1,463 $667K
70450 Computed tomography, head or brain; without contrast material <1% 11,451 $606K
80053 Comprehensive metabolic panel <1% 88,680 $587K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 18,752 $571K
96361 Intravenous infusion, hydration; each additional hour <1% 11,788 $563K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,616 $563K
36430 <1% 931 $517K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 8,385 $505K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 2,179 $505K
92587 <1% 2,070 $490K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,545 $471K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 14,761 $461K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 208 $433K
90853 Group psychotherapy (other than of a multiple-family group) <1% 14,252 $429K
95819 <1% 660 $418K
S9484 Crisis intervention mental health services, per hour <1% 540 $405K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 97,626 $399K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 11,083 $378K
93976 <1% 2,834 $352K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,286 $335K
36591 <1% 2,275 $325K
71046 Radiologic examination, chest; 2 views <1% 22,140 $321K
92567 <1% 2,719 $320K
OP250 <1% 131,973 $313K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,029 $305K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 6,651 $304K
92557 <1% 880 $275K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 4,241 $268K
96367 <1% 1,922 $265K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 8,531 $261K
OP272 <1% 20,279 $261K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,570 $240K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 2,537 $237K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 5,339 $227K
59025 Fetal non-stress test <1% 934 $227K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 4,283 $220K
99215 Doctor's office visit, returning patient (complex) <1% 923 $215K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 12,642 $213K
90791 Psychiatric diagnostic evaluation <1% 5,157 $212K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 9,561 $211K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,427 $208K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 1,598 $206K
72125 Computed tomography, cervical spine; without contrast material <1% 3,793 $203K
97161 <1% 3,745 $198K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,450 $195K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,734 $192K
93017 <1% 681 $190K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,581 $188K
H0046 Mental health services, not otherwise specified <1% 3,791 $186K
OP259 <1% 15,498 $182K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,395 $178K
92579 <1% 661 $170K
93458 <1% 109 $165K
93970 <1% 1,207 $164K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 361 $161K
76813 <1% 1,765 $160K
97010 <1% 18,887 $155K
90870 <1% 617 $152K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,664 $151K
36415 Collection of venous blood by venipuncture <1% 79,813 $137K
99204 Doctor's office visit, new patient (more involved) <1% 512 $132K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 874 $120K
92526 <1% 1,655 $118K
OP379 <1% 3,083 $116K
70486 <1% 1,229 $114K
95782 <1% 26 $113K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 7,851 $111K
76801 <1% 1,796 $109K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 16,606 $104K
76770 <1% 1,550 $103K
76820 <1% 1,765 $100K
84484 <1% 21,543 $98K
93971 <1% 2,067 $96K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 403 $88K
71045 Radiologic examination, chest; single view <1% 6,052 $87K
96376 <1% 4,394 $85K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 155 $85K
76821 <1% 1,194 $82K
76830 Ultrasound, transvaginal <1% 1,504 $79K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 554 $75K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 4,323 $73K
84443 Thyroid stimulating hormone (TSH) <1% 9,101 $72K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 29 $71K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,632 $71K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,879 $71K
71250 <1% 930 $70K
96417 <1% 207 $70K
97165 <1% 1,248 $66K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 9,372 $64K
97162 <1% 1,025 $58K
80048 Basic metabolic panel (calcium, ionized) <1% 9,833 $56K
94762 <1% 351 $55K
80061 Lipid panel <1% 6,240 $53K
97116 <1% 2,603 $52K
86885 <1% 8,914 $51K
J3490 Unclassified drugs <1% 6,878 $51K
76536 <1% 836 $50K
G0379 Direct admission of patient for hospital observation care <1% 418 $50K
99381 <1% 413 $48K
99203 Doctor's office visit, new patient (routine) <1% 256 $48K
92523 <1% 297 $48K
OP258 <1% 55,311 $47K
83735 <1% 18,292 $47K
42830 <1% 37 $47K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,598 $47K
90792 Psychiatric diagnostic evaluation with medical services <1% 2,591 $45K
93975 <1% 512 $45K
OP270 <1% 9,630 $44K
69421 <1% 38 $43K
81003 <1% 20,155 $43K
C1769 Guide wire <1% 2,076 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,611 $42K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,612 $42K
0002A <1% 1,302 $42K
90715 <1% 2,255 $41K
90834 Psychotherapy session, about 45 minutes <1% 1,141 $39K
85610 <1% 11,961 $38K
C9290 Injection, bupivacaine liposome, 1 mg <1% 718 $38K
0001A <1% 1,305 $38K
74018 <1% 3,742 $37K
77336 <1% 270 $37K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,059 $36K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 913 $35K
82962 <1% 14,249 $33K
73030 <1% 1,995 $32K
93041 <1% 381 $32K
83036 Hemoglobin; glycosylated (A1C) <1% 6,559 $32K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 55 $31K
97535 Self-care/home management training, each 15 minutes <1% 790 $31K
J2704 Injection, propofol, 10 mg <1% 14,363 $31K
83690 <1% 13,719 $31K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 501 $31K
83880 <1% 4,910 $30K
86901 <1% 11,008 $30K
73630 <1% 2,361 $30K
86900 <1% 10,669 $30K
85730 <1% 8,160 $29K
73610 <1% 2,384 $29K
70498 <1% 372 $28K
OP279 <1% 4,102 $28K
87040 <1% 3,297 $28K
92610 <1% 107 $28K
82077 <1% 6,479 $28K
58558 <1% 25 $27K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,541 $27K
OP682 <1% 114 $27K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,757 $26K
81001 <1% 16,710 $26K
72131 <1% 504 $25K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,547 $25K
81025 <1% 12,351 $25K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,156 $23K
87070 <1% 7,035 $23K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 449 $23K
84100 <1% 11,868 $23K
OP229 <1% 463 $23K
84439 <1% 3,883 $23K
70496 <1% 303 $23K
90670 <1% 806 $23K
J1644 Injection, heparin sodium, per 1000 units <1% 7,969 $23K
72141 <1% 101 $22K
84145 <1% 2,694 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 21,228 $22K
82728 <1% 3,045 $22K
85027 <1% 6,547 $21K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,551 $21K
73562 <1% 1,766 $20K
73130 <1% 1,771 $20K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 13,173 $19K
72110 <1% 812 $19K
90677 <1% 589 $19K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 15,340 $19K
86923 <1% 1,469 $19K
83605 <1% 3,859 $18K
84703 <1% 8,639 $18K
73110 <1% 1,294 $17K
83789 <1% 3,456 $17K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 19 $17K
99153 Mod sedat endo service >5yrs <1% 1,258 $17K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,715 $16K
82607 <1% 2,496 $16K
J1756 Injection, iron sucrose, 1 mg <1% 155 $16K
C1889 Implantable/insertable device, not otherwise classified <1% 33 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 15,248 $16K
84702 <1% 3,451 $16K
73590 <1% 1,155 $16K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 72 $15K
88304 <1% 1,569 $15K
86140 <1% 8,863 $15K
77072 <1% 368 $14K
G0390 Trauma response team associated with hospital critical care service <1% 86 $14K
90686 <1% 2,340 $14K
87088 <1% 2,860 $14K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 13 $13K
82803 <1% 1,863 $13K
54640 <1% 14 $13K
76870 <1% 514 $13K
97022 <1% 538 $12K
92550 <1% 85 $12K
83550 <1% 2,827 $12K
87186 <1% 2,835 $12K
0004A <1% 351 $12K
76818 <1% 245 $11K
96401 <1% 33 $11K
J0185 Injection, aprepitant, 1 mg <1% 36 $11K
73502 <1% 991 $11K
95716 <1% 20 $11K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 13 $10K
92611 <1% 36 $10K
74174 <1% 103 $10K
92588 <1% 31 $10K
73564 <1% 618 $10K
87077 <1% 3,071 $10K
85379 <1% 3,151 $9K
82550 <1% 2,917 $9K
95700 <1% 35 $9K
82746 <1% 1,626 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,951 $9K
54830 <1% 12 $9K
80143 <1% 1,815 $8K
G0008 Administration of influenza virus vaccine <1% 479 $8K
85651 <1% 4,361 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,365 $8K
85045 <1% 2,468 $8K
99152 <1% 1,359 $8K
P9016 Red blood cells, leukocytes reduced, each unit <1% 46 $8K
80179 <1% 1,743 $8K
G0451 Development testing, with interpretation and report, per standardized instrument form <1% 311 $8K
83540 <1% 2,624 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,333 $8K
88307 <1% 355 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,583 $7K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 35 $7K
C1760 Closure device, vascular (implantable/insertable) <1% 282 $7K
J2785 Injection, regadenoson, 0.1 mg <1% 65 $7K
76000 <1% 424 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 630 $7K
J2060 Injection, lorazepam, 2 mg <1% 2,887 $7K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 95 $7K
J1815 Injection, insulin, per 5 units <1% 1,047 $7K
80164 <1% 834 $6K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 154 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 539 $6K
82570 <1% 2,291 $6K
88313 <1% 1,266 $6K
88342 <1% 653 $6K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 2,806 $6K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,344 $6K
76825 <1% 13 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 939 $6K
70491 <1% 86 $6K
A9585 Injection, gadobutrol, 0.1 ml <1% 660 $6K
90651 <1% 98 $6K
94770 <1% 38 $6K
83615 <1% 3,360 $5K
73080 <1% 474 $5K
82784 <1% 650 $5K
87581 <1% 910 $5K
87486 <1% 910 $5K
96523 <1% 44 $5K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,521 $5K
73090 <1% 442 $5K
96127 <1% 896 $5K
82248 <1% 1,173 $5K
76775 <1% 129 $5K
95800 <1% 17 $5K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 2,677 $5K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 14 $4K
72100 <1% 303 $4K
97166 <1% 41 $4K
74019 <1% 392 $4K
L8699 Prosthetic implant, not otherwise specified <1% 263 $4K
72170 <1% 285 $4K
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 1,943 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 4,243 $4K
84550 <1% 2,892 $4K
86480 <1% 95 $4K
12001 <1% 124 $4K
0064A <1% 121 $4K
29580 <1% 34 $4K
90734 <1% 74 $4K
J3480 Injection, potassium chloride, per 2 meq <1% 1,773 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,310 $3K
88312 <1% 1,083 $3K
74022 <1% 294 $3K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 700 $3K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 707 $3K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,479 $3K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,027 $3K
87999 <1% 1,254 $3K
90688 <1% 221 $3K
84156 <1% 1,616 $3K
80320 <1% 451 $3K
0071A <1% 73 $3K
88300 <1% 1,354 $3K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 791 $3K
0072A <1% 64 $3K
84480 <1% 224 $3K
73552 <1% 230 $3K
93880 <1% 39 $3K
76604 <1% 129 $3K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 47 $3K
80047 <1% 2,003 $3K
0012A <1% 94 $3K
87205 <1% 696 $3K
82010 <1% 1,010 $3K
73140 <1% 289 $3K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 62 $2K
97018 <1% 51 $2K
J3370 Injection, vancomycin hcl, 500 mg <1% 481 $2K
0011A <1% 86 $2K
90723 <1% 645 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 19 $2K
90681 <1% 801 $2K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 2,037 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,509 $2K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 30 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,364 $2K
74230 <1% 36 $2K
97035 <1% 33 $2K
99442 <1% 36 $2K
90656 <1% 316 $2K
82247 <1% 472 $2K
82378 <1% 135 $2K
86780 <1% 117 $2K
29125 <1% 77 $2K
85055 <1% 59 $1K
C9113 Injection, pantoprazole sodium, per vial <1% 2,104 $1K
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 1,131 $1K
94760 <1% 35 $1K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 588 $1K
D1110 Prophylaxis - adult <1% 139 $1K
73700 <1% 40 $1K
86308 <1% 471 $1K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 45 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 1,162 $1K
80074 <1% 85 $1K
90847 Family psychotherapy with the patient present, 50 minutes <1% 33 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,112 $1K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 16 $1K
10060 <1% 46 $1K
12002 <1% 41 $1K
82043 <1% 429 $1K
87641 <1% 253 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 1,367 $1K
J3360 Injection, diazepam, up to 5 mg <1% 331 $1K
76998 <1% 18 $1K
90472 Immunization administration, each additional vaccine (list separately) <1% 82 $1K
87420 <1% 580 $1K
86618 <1% 203 $985.70
D0120 Dental checkup, returning patient <1% 110 $983.50
86592 <1% 509 $973.70
88173 <1% 27 $930.26
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 21 $927.72
J0360 Injection, hydralazine hcl, up to 20 mg <1% 602 $910.38
76857 <1% 12 $892.31
86803 <1% 135 $884.07
88341 <1% 27 $882.93
86850 <1% 177 $873.24
76001 <1% 42 $871.16
85014 <1% 2,094 $855.15
87640 <1% 259 $840.30
73560 <1% 87 $830.74
85378 <1% 191 $818.18
87147 <1% 631 $798.15
97164 <1% 12 $789.02
J3411 Injection, thiamine hcl, 100 mg <1% 165 $777.92
80076 <1% 216 $747.52
0124A <1% 28 $741.86
83520 <1% 48 $725.60
84132 <1% 272 $690.04
82977 <1% 904 $685.47
87340 <1% 197 $683.86
82150 <1% 333 $678.85
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 40 $671.18
Q3014 Telehealth originating site facility fee <1% 55 $627.36
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 605 $602.91
J1940 Injection, furosemide, up to 20 mg <1% 149 $597.31
Q9953 Injection, iron-based magnetic resonance contrast agent, per ml <1% 25 $596.07
86617 <1% 71 $585.94
84560 <1% 268 $577.98
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 299 $566.88
86141 <1% 398 $542.52
82140 <1% 179 $541.53
96040 <1% 13 $539.82
J3371 Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg <1% 72 $513.83
0031A <1% 16 $510.64
86038 <1% 82 $507.72
84481 <1% 44 $507.59
86870 <1% 17 $496.41
80177 <1% 69 $492.62
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 762 $488.27
J2469 Injection, palonosetron hcl, 25 mcg <1% 46 $478.09
97799 <1% 58 $454.74
90716 <1% 76 $453.00
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 57 $437.66
90697 <1% 569 $430.81
12011 <1% 24 $428.68
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 178 $418.31
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 458 $416.77
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 397 $413.63
84153 <1% 62 $406.37
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 14 $398.27
J7030 Infusion, normal saline solution , 1000 cc <1% 616 $383.71
84146 <1% 14 $365.89
90647 <1% 331 $354.59
72040 <1% 27 $330.49
J1920 Injection, labetalol hydrochloride, 5 mg <1% 349 $294.67
90707 <1% 115 $292.69
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 446 $272.12
J1596 Injection, glycopyrrolate, 0.1 mg <1% 534 $261.01
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 44 $254.60
87899 <1% 101 $249.81
86706 <1% 69 $241.99
82565 <1% 678 $237.23
73060 <1% 28 $234.89
88112 <1% 21 $230.14
83970 <1% 25 $217.66
88172 <1% 12 $209.64
J0780 Injection, prochlorperazine, up to 10 mg <1% 114 $207.92
86704 <1% 54 $181.14
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 144 $177.40
85384 <1% 118 $177.23
OP637 <1% 19,885 $176.19
87076 <1% 28 $160.60
82533 <1% 16 $160.16
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 14 $156.98
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 66 $151.42
87390 <1% 12 $148.14
J1953 Injection, levetiracetam, 10 mg <1% 64 $141.52
86665 <1% 33 $139.77
84436 <1% 27 $137.82
86769 <1% 16 $131.05
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 403 $122.49
80069 <1% 18 $119.82
90633 <1% 479 $118.59
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 78 $111.38
C1770 Imaging coil, magnetic resonance (insertable) <1% 14 $107.91
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 28 $97.82
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 69 $96.89
90671 <1% 115 $96.00
87015 <1% 97 $90.48
J1171 Injection, hydromorphone, 0.1 mg <1% 158 $76.86
J2470 Injection, pantoprazole sodium, 40 mg <1% 226 $75.16
86431 <1% 15 $64.81
86364 <1% 15 $64.23
84165 <1% 13 $52.06
86664 <1% 15 $50.10
82270 <1% 13 $49.32
99151 <1% 12 $48.98
J0290 Injection, ampicillin sodium, 500 mg <1% 39 $48.71
73070 <1% 23 $43.91
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 27 $38.54
87045 <1% 40 $36.00
87536 <1% 14 $35.60
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 16 $34.91
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 36 $34.27
D1206 Topical application of fluoride varnish <1% 26 $33.00
J3590 Unclassified biologics <1% 203 $31.50
J7510 Prednisolone oral, per 5 mg <1% 169 $29.32
84300 <1% 13 $28.80
J2550 Injection, promethazine hcl, up to 50 mg <1% 118 $26.58
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 85 $23.86
J8540 Dexamethasone, oral, 0.25 mg <1% 56 $15.98
90380 <1% 32 $15.57
Q0239 Injection, bamlanivimab-xxxx, 700 mg <1% 17 $14.00
90381 <1% 28 $12.47
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 160 $10.63
84155 <1% 15 $9.04
91300 <1% 2,484 $9.01
90700 <1% 36 $3.00
J3372 Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg <1% 22 $1.31
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 109 $1.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 99 $1.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 47 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 0% 23 $0.00
91312 0% 28 $0.00
91301 0% 192 $0.00
91306 0% 110 $0.00
87507 0% 12 $0.00
86361 0% 16 $0.00
91307 0% 119 $0.00
Q0222 Injection, bebtelovimab, 175 mg 0% 18 $0.00
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg 0% 69 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAND, RICHARD (SVP FINANCE)
Same official

Other billing entities under HAND, RICHARD

Full network →
ProviderLocationPaid
HMH Hospitals CorporationManahawkin, NJ$34.80M
Community Hospital Group, INCEdison, NJ$954K
Hackensack Meridian Urgent Care Plus PCHoboken, NJ$948K
HMH Carrier Behavioral Health INCBelle Mead, NJ$669K
Community Hospital Group, INCEdison, NJ$453K
Hackensack Meridian Ambulatory Care, INC.Holmdel, NJ$170K
Meridian Cardiovascular Interpretive Services PCNeptune, NJ$145K
Hackensack Meridian Ambulatory Care, INC.Eatontown, NJ$382.20
Hackensack Meridian Ambulatory Care, INC.Holmdel, NJ$276.57
Hackensack Meridian Ambulatory Care, INC.Hackensack, NJ$76.92
Hackensack Meridian Ambulatory Care, INC.Shrewsbury, NJ$39.35
Hackensack Meridian Ambulatory Care, INC.North Bergen, NJ$31.11
Hackensack Meridian Ambulatory Care, INC.Red Bank, NJ$25.96
Hackensack Meridian Ambulatory Care, INC.Ocean Grove, NJ$0.00
Hackensack Meridian Ambulatory Care, INC.Brick, NJ$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.